Skip to main content

Department of Medicine

About Us

Dedicated to the future of care

The Department of Medicine provides residents with a thorough, broad-based education while giving patients individualized care through Feinberg-affiliated hospitals and care sites and conducting high-level basic and clinical research through our 12 specialized internal medicine divisions.

The unique culture at the Department of Medicine is built on its rich history of research and clinical innovation embedded in an exceptional clinical environment, driven by faculty and staff whose commitment and talent create patient care improvements through scientific advance.

These extraordinary strengths allow the Department to adapt to tremendous challenges and opportunities that are arising in healthcare. We have seen more change over recent years than in many preceding decades. As each of us contributes to expanding what we can achieve, we are driven by the same core mission: Patients First.”

Susan E. Quaggin, MD, FRCP(C), FASN

Read Message from the Chair

What We Do

Faculty Spotlight

Gary Noskin

Professor of Medicine (Infectious Diseases)

Antimicrobial resistance, Infection of the immunocompromised host, Nosocomial infections

Arnold M Tatar

Clinical Assistant Professor of Medicine (General Internal Medicine)

Preventive medicine through lifestyle counseling, early detection, and treatment to achieve optimal control and avoid complicatons.

Kalliopi P Siziopikou

Professor of Pathology (Breast Pathology) and Medicine (Hematology and Oncology)

Dr. Siziopikou's subspecialty focus is on breast tumor markers and molecular diagnostics in breast cancer. Her research interests center around molecular markers of prognostic and predictive significance in breast cancer.

Linda A Teplin

Professor of Psychiatry and Behavioral Sciences (General Psychiatry), Medicine (Infectious Diseases) and Weinberg College of Arts and Sciences

Dr. Linda A. Teplin is the Director of the Health Disparities and Public Policy Program in the Department of Psychiatry and Behavioral Sciences. She is the Primary Investigator for the Northwestern Project, the first large-scale longitudinal study of mental health needs and outcomes of delinquent youth after detention. For nearly two decades, the Northwestern Project has tracked and re-interviewed nearly 2000 participants, first recruited when they entered the Cook County Temporary Juvenile Detention center when they were ages 10-18 years. The Northwestern Project assesses a broad range of out...

Melinda R Ring

Clinical Associate Professor of Medicine (General Internal Medicine) and Medical Social Sciences (Intervention Science)

Research interest: Examining the potential benefits of integrative medicine therapies (complementary and alternative medicine) for a range of conditions.

Robert M Rosa

Professor of Medicine (Nephrology and Hypertension)

Hypertension; Racial differences in electrolyte metabolism and water balance; chronic renal failure.

G Randy Smith, Jr.

Associate Professor of Medicine (Hospital Medicine)

Randy Smith is a career hospitalist and currently serves as Unit Medical Director for Unit 16 West at Northwestern Memorial Hospital. He has served as an implementation mentor in four Federally or privately funded multihospital quality improvement programs. His quality improvement experience includes direct involvement in development projects at thirteen hospitals throughout his career, with project focus ranging from prevention of unplanned readmissions, optimization of hospital throughput, design of handover systems and diagnosis notification systems for discharged patients, inpatient medica...

Lenore F Soglin

Assistant Professor of Medicine (General Internal Medicine)

Primary care internal medicine, Women's healthcare, intimate partner violence

Jeffrey A Sosman

Professor of Medicine (Hematology and Oncology)

I have been an active clinical investigator vested in the immune-based therapy of melanoma. This has led to my role in the clinical development of initially Interleukin-2 and more recently anti-CTLA-4 and anti-PD1/PDL-1. While checkpoint therapy has been a great breakthrough in cancer treatment, additional immune-based strategies are still critically needed. Efforts to identify mechanisms of resistance to checkpoint inhibitors and approaches to overcome de novo and acquired resistance are one of my major interest. In addition I have ongoing efforts in the personalized therapy of melanoma with ...